FILE PHOTO: Syringes filled with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are prepared at the CHIREC Delta Hospital in Brussels, Belgium January 21, 2021. REUTERS/Yves Herman/File Photo
LONDON/FRANKFURT (Reuters) - Pfizer and BioNTech have agreed to supply their COVID-19 vaccine to the World Health Organization co-led COVAX vaccine access scheme, two sources familiar with the deal said, the latest in a series of shots to be included in the project aimed at lower-income countries.
The deal is expected to be announced on Friday, according to the sources, who declined to be named due to the confidentiality of the agreement.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
